Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T7OE
|
|||
| Former ID |
DIB007441
|
|||
| Drug Name |
NEO100
|
|||
| Indication | Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [1] | |
| Malignant glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [2] | ||
| Recurrent malignant glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [3] | ||
| Company |
Neonc technologies
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Neonc technologies. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.